Ignite Creation Date:
2025-12-24 @ 1:12 PM
Ignite Modification Date:
2026-03-01 @ 9:54 PM
Study NCT ID:
NCT01397695
Status:
COMPLETED
Last Update Posted:
2019-09-06
First Post:
2011-07-18
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Topical Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)
Sponsor:
University of California, San Diego
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-06
Start Date Type:
ACTUAL
Primary Completion Date:
2014-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-01
Completion Date Type:
ACTUAL
First Submit Date:
2011-07-18
First Submit QC Date:
None
Study First Post Date:
2011-07-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-08-15
Results First Submit QC Date:
None
Results First Post Date:
2019-09-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-08-15
Last Update Post Date:
2019-09-06
Last Update Post Date Type:
ACTUAL